• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > ASH 2020

Category

ASH 2020
  • Clinical practice
  • Science
  • Clinical trials
  • Editor's pick
  • Health Innovation
  • Prevention
  • Pharma News

ASH 2020

Subcutaneous daratumumab plus pomalidomide-dexamethasone: an effective treatment option for M...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Immune dysregulation in MDS and MPN: An immunological mess – Part 1
  • BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 1
  • Diagnosis and treatment of Waldenström Macroglobulinaemia
  • Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series
  • Outpatient management of patients with acute myeloid leukaemia during intensive consolidation chemotherapy: A feasibility study
  • Journal Scan
  • New haematology reimbursements in Belgium
ASH 2020

Dose-escalation of oral azacitidine provides clinical benefit to acute myeloid leukaemia patie...

Read more
ASH 2020

Asciminib as a third line treatment for chronic phase chronic myeloid leukaemia

Read more
ASH 2020

Gene therapy offers new perspectives in treatment of haemophilia B

Read more
ASH 2020

Updated results from the phase III MURANO trial

Read more
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023